1398 BRIVANIB VERSUS PLACEBO IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC) WHO FAILED OR WERE INTOLERANT TO SORAFENIB: RESULTS FROM THE PHASE 3 BRISK-PS STUDY

Authors:
  • JLJ.M. Llovet
    J.M. Llovet
  • TDT. Decaens
    T. Decaens
  • JRJ.-L. Raoul
    J.-L. Raoul
  • EBE. Boucher
    E. Boucher
  • MKM. Kudo
    M. Kudo
  • CCC. Chang
    C. Chang
  • YKY.-K. Kang
    Y.-K. Kang
  • EAE. Assenat
    E. Assenat
  • HLH.-Y. Lim
    H.-Y. Lim
  • VBV. Boige
    V. Boige
  • LFL. Fartoux
    L. Fartoux

Abstract
No abstract available